Category: Supply Chain

$163B in surplus inventory wasted annually: Report

About 8 percent of global stock perishes or is thrown away every year, translating to about $163 billion worth of wasted inventory, Bloomberg reported Nov. 10, citing a new report from materials supplier Avery Dennison. 

Possible job cuts, price increases and 8 more supply chain updates

Here are nine supply chain updates for ASC leaders to know that Becker’s has reported since Nov. 3:

Top 25 drugs used in outpatient settings

Triamcinolone acetonide, a corticosteroid, is the most commonly administered drug in outpatient procedures, according to a recent report by Definitive Healthcare. 

Bryan Health picks Medline as primary supplier

After working with a different supplier for more than three decades, Lincoln, Neb.-based Bryan Health chose Medline as its main vendor in a deal worth $140 million. 

How to tackle end-of-year disruptions and 8 more supply chain updates

Here are nine supply chain updates for ASC leaders to know that Becker’s has reported since Oct. 19:

FDA warns of tracheostomy tube shortage

There is a national shortage of tracheostomy tubes, including ICU Medical’s Bivona tubes, and the dearth is more likely to affect pediatric patients because there are few alternative products, the FDA said Oct. 31. 

A vice president’s tips on cost reduction and 6 more supply chain updates

Here are seven supply chain updates for ASC leaders to know that Becker’s has reported since Oct. 12:

3 winter disruptions hospital leaders should brace for

As hospital supply chains endure inflationary pressures, the surge of multiple viruses and typical “end-of-the-year chaos,” medical supply experts told Becker’s their top concerns heading into 2022’s winter.

Philips to cut 4,000 jobs to save $296M

Philips, an Amsterdam-based medical device company, will cut 4,000 jobs as it weathers a recall of 18 million sleep apnea masks, The Wall Street Journal reported Oct. 24. 

Abbott plans $500M formula plant

The baby powder shortage lasted months after Abbott Laboratories shuttered its main manufacturing site for the product, and the company is now planning a new $500 million facility, CBS News reported Oct. 21.